Skip to content
10-Q

Quarterly Report

Concert Pharmaceuticals, Inc.

0001367920-21-000068

← back to feed
Filed
Nov 9, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 5, 2021 34.66M sh
Current Liabilities Q3 2021 · Sep 30, 2021 $12.02M
Current Liabilities Q3 2021 · Dec 31, 2020 $10.18M
Total Liabilities Q3 2021 · Sep 30, 2021 $29.05M
Total Liabilities Q3 2021 · Dec 31, 2020 $28.1M
Current Assets Q3 2021 · Sep 30, 2021 $112.91M
Current Assets Q3 2021 · Dec 31, 2020 $142.72M
Total Assets Q3 2021 · Sep 30, 2021 $128.21M
Total Assets Q3 2021 · Dec 31, 2020 $159.26M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $77.2M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $33.68M
Shares Diluted Q3 2021 · Sep 30, 2020 31.55M sh
Shares Diluted Q3 2021 · Sep 30, 2020 30.71M sh
Capex Q3 2021 · Sep 30, 2020 $185K
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$52.81M
Stockholders Equity Q3 2021 · Sep 30, 2020 $127.94M
Stockholders Equity Q3 2021 · Jun 30, 2020 $144.09M
Stockholders Equity Q3 2021 · Mar 31, 2020 $154.48M
Stockholders Equity Q3 2021 · Dec 31, 2019 $101.46M
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.60
Eps Diluted Q3 2021 · Sep 30, 2020 −$1.71
Eps Basic Q3 2021 · Sep 30, 2020 −$0.60
Eps Basic Q3 2021 · Sep 30, 2020 −$1.71
Sga Expense Q3 2021 · Sep 30, 2020 $4.51M
Sga Expense Q3 2021 · Sep 30, 2020 $13.92M
Rd Expense Q3 2021 · Sep 30, 2020 $16.35M
Rd Expense Q3 2021 · Sep 30, 2020 $45.12M
Net Income Q3 2021 · Sep 30, 2020 −$18.91M
Net Income Q3 2021 · Sep 30, 2020 −$52.38M
Net Income Q3 2021 · Jun 30, 2020 −$12.99M
Net Income Q3 2021 · Mar 31, 2020 −$20.48M
Operating Income Q3 2021 · Sep 30, 2020 −$19.36M
Operating Income Q3 2021 · Sep 30, 2020 −$51.14M
Revenue Q3 2021 · Sep 30, 2020 $1.5M
Revenue Q3 2021 · Sep 30, 2020 $7.9M
Revenue Q3 2021 · Mar 31, 2018 $10.5M
Revenue Q3 2021 · Mar 19, 2018 $10.5M